Research & Development in
Sarnen

Swiss Fire Protection Research & Development AG

Since 2016 · 1–10 empl.

The core activity of Swiss Fire Protection Research & Development AG is research and development in the field of fire protection, particularly in the investigation of causes of tank fires.

NuVentus AG

Since 2023 · 11–20 empl.

NuVentus AG develops and sells dental implant systems and related surgical and prosthetic components, including the NV.C™ implant featuring a Sinewave Profile and coronal flutes designed to create space and preserve bone fragments during osteotomy. The company also supplies surgery sets, implant packages and the Nuventus App for inventory management and ordering; NV.C™ implants are prosthetically compatible with certain Internal Conical Connection components.

Hymson Novolas AG

Since 2025 · 1–10 empl.

Hymson Novolas AG develops and manufactures laser plastic welding systems and related accessories for industrial applications.

InfinetaMed AG

Since 2024 · 1–10 empl.

InfinetaMed AG provides lean process management for medical device companies and supports the planning and execution of development and market-readiness projects. Services include concept assessment, R&D coordination, project management, QA/RA support and business management, including assistance with regulatory registrations.

SILVER STALLION GMBH

Since 2021 · 1–10 empl.

SILVER STALLION GMBH is a company that conducts research in cannabis medicine, wellness and related medical technology and machinery. It holds patents for a method to extract cannabinoids, flavonoids and terpenes (protected in multiple countries) and manufactures proprietary equipment for sub‑critical CO2 extraction without winterization, producing extracts intended for applications such as cosmetics, veterinary products and candles.

Leico Leiser AG

Since 1977 · 1–10 empl.

Swiss Microsystems AG

Since 1996 · 1–10 empl.

Pertexe AG

Since 2009 · 1–10 empl.

SRC AG

Since 2020 · 1–10 empl.

SP Cube AG

Since 2022 · 1–10 empl.

Novel Lab AG

Since 2022 · 1–10 empl.

Future Clinical Trials GmbH

Since 2023 · 1–10 empl.